Wyse, PhD, J. J., Morasco, PhD, B. J., Dobscha, MD, S. K., Demidenko, BS, M. I., Meath, MPH, T. H. A., & Lovejoy, PhD, MPH, T. I. (2018). Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified. Journal of Opioid Management, 14(4), 295–303. https://doi.org/10.5055/jom.2018.0461